Librerías de compuestos
Las bibliotecas de compuestos son colecciones de compuestos almacenados que se utilizan ampliamente para identificar eficientemente moléculas de interés. Estas bibliotecas son herramientas esenciales en la investigación y el desarrollo, especialmente en la búsqueda de nuevos fármacos, al permitir la realización de cribados exhaustivos y controles de calidad de manera eficiente. Las bibliotecas de compuestos son útiles para realizar análisis muy exigentes, reduciendo considerablemente el costo y el tiempo asociados con estos procesos. En CymitQuimica, ofrecemos una extensa gama de bibliotecas de compuestos de alta calidad, diseñadas para satisfacer las necesidades de investigación y desarrollo en diversas áreas científicas e industriales. Nuestro catálogo incluye bibliotecas con una gran variedad de compuestos, facilitando la identificación y desarrollo de moléculas con potencial terapéutico y otras aplicaciones innovadoras.
Productos de "Librerías de compuestos"
Ordenar por
Rare Natural Product Library
A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);Forma y color:Odour SolidRef: TM-L6900
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarAnti-Tumor Natural Product Library
A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);Forma y color:Odour SolidRef: TM-L6700
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarToxic Compound Library
A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);Forma y color:Odour SolidRef: TM-L5500
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarCardiotoxicity Compound Library
A unique collection of 131 cardiotoxicity inducing compounds for toxicological study;Forma y color:Odour SolidRef: TM-L4900
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarMacrocyclic Compound Library
210 macrocyclic compounds of known activity for high-throughput, high-content screening;Forma y color:Odour SolidRef: TM-L9300
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarBioactive Compound Library
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, andForma y color:Odour SolidRef: TM-L4000
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarTyrosine Kinase Inhibitor Library
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase relatedForma y color:Odour SolidRef: TM-L2200
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarGinsenoside Rb3
CAS:Ginsenoside Rb3 has anti-myocardial ischemia-reperfusion injury, neuroprotective, antidepressant-like, and antioxidant effects, it also possesses the potential of the clinical use in preventing and treating diabetes. Ginsenoside Rb3 significantly attenuates the changes of creatine kinase activity and lactate dehydrogenase activity, exhibits inhibitory effect on TNFα-induced NF-κB transcriptional activity with an IC50 of 8.2 μM in 293T cell lines, it also inhibits the induction of COX-2 and iNOS mRNA.Fórmula:C53H90O22Pureza:95%~99%Peso molecular:1079.28Anti-Cardiovascular Disease Compound Library
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);Forma y color:Odour SolidRef: TM-L5400
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultar20(R)-Ginsenoside Rh2
CAS:Ginsenoside Rh2 is one of the most active components of red ginseng, controlling cancer and other metabolic diseases including osteoclast differentiation; ginsenoside Rh2 can suppress RANKL-induced osteoclast differentiation in vitro and in vivo through the regulation of c-Fos and NFATc1 expressions, not excluding the involvement of NF-κB and ERK, it is also suggested to be developed as a therapeutic drug for prevention and treatment of osteoporosis.Fórmula:C36H62O8Pureza:20%, 95%, 98%Peso molecular:622.873Natural Product Derivatives Library
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).Forma y color:Odour SolidAnti-Hypertension Compound Library
678 hypertension-related small molecules for high-throughput and high-content screening.Forma y color:Odour SolidRef: TM-L7110
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarNucleotide Compound Library
A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-Forma y color:Odour SolidRef: TM-L1720
1mgA consultar50µl*10 (DMSO)3.064,00€30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultarAntibiotics Library
A unique collection of 692 compounds with antibiotic activity for new antibacterial drug screening;Forma y color:Odour SolidRef: TM-L4400
1mgA consultar30μL*10mM (DMSO)A consultar50μL*10mM (DMSO)A consultar100μL*10mM (DMSO)A consultar250μL*10mM (DMSO)A consultar
